AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Bio-Rad to Report Second-Quarter 2021 Financial Results, Thursday, July 29, 2021

July 14, 2021 GMT

HERCULES, Calif.--(BUSINESS WIRE)--Jul 14, 2021--

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the second quarter 2021 on Thursday, July 29, 2021, following the close of the market. The company will discuss these results in a conference call scheduled for 3 PM Pacific Time (6 PM Eastern Time) that day.

To listen, call 855-779-9068 within the U.S. or 631-485-4862 outside the U.S., passcode: 5382265. You may also listen to the conference call live via a webcast that is available on the “Investor Relations” section of our website under “Quarterly Results” at bio-rad.com. The webcast will be available for up to a year.

ADVERTISEMENT

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with approximately 7,700 employees worldwide. Bio-Rad had revenues exceeding $2.5 billion in 2020. Please visit bio-rad.com for further information.

View source version on businesswire.com:https://www.businesswire.com/news/home/20210714005883/en/

CONTACT: Investor Contact:

Bio-Rad Laboratories, Inc.

Edward Chung, Vice President, Investor Relations

Investor Relations

510-724-7000

ir@bio-rad.comMedia Contact:

Bio-Rad Laboratories, Inc.

Tina Cuccia, Manager, Corporate Communications

510-741-6063

tina_cuccia@bio-rad.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: RESEARCH PROFESSIONAL SERVICES PHARMACEUTICAL MEDICAL DEVICES INFECTIOUS DISEASES CLINICAL TRIALS SCIENCE BIOTECHNOLOGY MEDICAL SUPPLIES STEM CELLS FINANCE HEALTH DIABETES

SOURCE: Bio-Rad Laboratories, Inc.

Copyright Business Wire 2021.

PUB: 07/14/2021 04:15 PM/DISC: 07/14/2021 04:17 PM

http://www.businesswire.com/news/home/20210714005883/en